NEFAZODONE HYDROCHLORIDE Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Nefazodone Hydrochloride, and when can generic versions of Nefazodone Hydrochloride launch?
Nefazodone Hydrochloride is a drug marketed by Ani Pharms, Aurobindo Pharma Usa, Chartwell Rx, Dr Reddys Labs Inc, Ivax Sub Teva Pharms, Roxane, Sun Pharm Inds Ltd, Teva, and Watson Labs. and is included in nine NDAs.
The generic ingredient in NEFAZODONE HYDROCHLORIDE is nefazodone hydrochloride. There are four drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the nefazodone hydrochloride profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Nefazodone Hydrochloride
A generic version of NEFAZODONE HYDROCHLORIDE was approved as nefazodone hydrochloride by TEVA on September 16th, 2003.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for NEFAZODONE HYDROCHLORIDE?
- What are the global sales for NEFAZODONE HYDROCHLORIDE?
- What is Average Wholesale Price for NEFAZODONE HYDROCHLORIDE?
Summary for NEFAZODONE HYDROCHLORIDE
| US Patents: | 0 |
| Applicants: | 9 |
| NDAs: | 9 |
| Finished Product Suppliers / Packagers: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 103 |
| Clinical Trials: | 16 |
| Patent Applications: | 1,195 |
| DailyMed Link: | NEFAZODONE HYDROCHLORIDE at DailyMed |
Recent Clinical Trials for NEFAZODONE HYDROCHLORIDE
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Instituto Nacional de Salud Publica, Mexico | Phase 3 |
| Laboratorios Grossman, S.A. | Phase 3 |
| Durham VA Medical Center | Phase 2 |
Pharmacology for NEFAZODONE HYDROCHLORIDE
| Drug Class | Serotonin Reuptake Inhibitor |
Anatomical Therapeutic Chemical (ATC) Classes for NEFAZODONE HYDROCHLORIDE
US Patents and Regulatory Information for NEFAZODONE HYDROCHLORIDE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Watson Labs | NEFAZODONE HYDROCHLORIDE | nefazodone hydrochloride | TABLET;ORAL | 076073-003 | Sep 16, 2003 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Sun Pharm Inds Ltd | NEFAZODONE HYDROCHLORIDE | nefazodone hydrochloride | TABLET;ORAL | 076409-003 | Sep 16, 2003 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Roxane | NEFAZODONE HYDROCHLORIDE | nefazodone hydrochloride | TABLET;ORAL | 076196-004 | Sep 16, 2003 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Sun Pharm Inds Ltd | NEFAZODONE HYDROCHLORIDE | nefazodone hydrochloride | TABLET;ORAL | 076409-004 | Sep 16, 2003 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Roxane | NEFAZODONE HYDROCHLORIDE | nefazodone hydrochloride | TABLET;ORAL | 076196-005 | Sep 16, 2003 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Ani Pharms | NEFAZODONE HYDROCHLORIDE | nefazodone hydrochloride | TABLET;ORAL | 076072-001 | Sep 16, 2003 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
